ML17102B287

From kanterella
Jump to navigation Jump to search
Shine Medical Technologies, Inc. - Acknowledgment of Receipt of Periodic Reports on Construction Permit Conditions
ML17102B287
Person / Time
Site: SHINE Medical Technologies
Issue date: 05/24/2017
From: Steven Lynch
NRC/NRR/DPR/PRLB
To: Piefer G
SHINE Medical Technologies
Lynch S, NRR/DPR/PRLB, 301-415-1524
References
Download: ML17102B287 (4)


Text

May 24, 2017 Gregory Piefer, Ph.D.

Chief Executive Officer SHINE Medical Technologies, Inc.

101 E. Milwaukee Street, Suite 600 Janesville, WI 53545

SUBJECT:

SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF RECEIPT OF PERIODIC REPORTS ON CONSTRUCTION PERMIT CONDITIONS

Dear Dr. Piefer:

In order to verify certain design developments related to nuclear criticality safety and radiation protection in the SHINE Medical Technologies, Inc. (SHINE) Radioisotope Production Facility (RPF), the U.S. Nuclear Regulatory Commission (NRC) collects periodic reports containing the information set forth in Section 3.D.(1) of SHINE Construction Permit No. CPMIF-001.

By letter dated February 24, 2017 (Agencywide Documents Access and Management System

[ADAMS] Accession No. ML17055A573), SHINE submitted to the NRC its second periodic report on nuclear criticality safety and radiation protection consistent with Section 3.D.(1) of its construction permit, CPMIF-001. SHINE submitted to the NRC its first periodic report on August 25, 2016 (ADAMS Accession No. ML16238A034).

As described in its two periodic reports, SHINE has performed limited work on four of the five license conditions described in Section 3.D.(1) of its construction permit. In support of developing the technical basis for the design of the criticality accident alarm system in License Condition 3.D.(1)(a), SHINE has worked with criticality accident alarm system equipment vendors on the development of an initial estimate of equipment quantities. With respect to the criticality safety considerations described in License Conditions 3.D.(1)(b) - (d), SHINE has indicated that it has begun to prepare programmatic nuclear criticality safety documentation to be used for the development of nuclear criticality safety evaluations for the SHINE RPF. At this time, SHINE has not developed any additional design information on the RPF supercells, tank vaults containing the liquid waste storage tanks, evaporation hot cells, or liquid waste solidification hot cells, demonstrating shielding and occupancy times within the RPF are consistent with as low as is reasonably achievable practices and dose requirements of Title 10 of the Code of Federal Regulations Part 20, Standards for Protection against Radiation, as described in License Condition 3.D.(1)(e).

As of the writing of this letter, SHINE has neither initiated construction of its proposed facility nor submitted any additional design information as part of an operating license application for NRC review under Docket No. 50-608.

G. Piefer Based upon the information provided in SHINEs periodic reports, the status of activities authorized under Construction Permit No. CPMIF-001, and the status of applications submitted under Docket No. 50-608, no NRC action is necessary on SHINEs periodic reports at this time.

The NRC may request that SHINE provide clarifying or more detailed information in order to verify certain design developments as set forth in Section 3.D.(1) of SHINEs construction permit if the NRC considers this information necessary prior to the completion of construction. This may include requests that SHINE make reference material available via electronic reading room or meet with NRC staff to support the planning and conducting of NRC inspections during construction.

If you have any questions, please contact Steven Lynch at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.

Sincerely,

/RA/

Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-608 cc: See next page

SHINE External Stakeholder Mailing List Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc.

101 E. Milwaukee Street, Suite 600 Janesville, WI 53545 Jeff Chamberlin National Nuclear Security Administration, NA-231 U.S. Department of Energy 1000 Independence Ave SW Washington, DC 20585 Mark Paulson Supervisor Radiation Protection Section Wisconsin Department of Health Services P.O. Box 2659 Madison, WI 53701-2659 TRTR Newsletter University of Florida Department of Nuclear Engineering Sciences 202 Nuclear Sciences Center Gainesville, FL 32611 Mark Freitag City Manager P.O. Box 5005 Janesville, WI 53547-5005 Bill McCoy 1326 Putnam Avenue Janesville, WI 53546 Alfred Lembrich 541 Miller Avenue Janesville, WI 53548 Gerald and Muriel Bumgarner 1735 S Osborne Ave Janesville, WI 53546

ML17102B287; *concurred via email NRR-088 OFFICE NRR/DPR/PRLB/PM* NRR/DPR/PROB/LA* NMSS/FCSE/ECB NAME SLynch NParker YFaraz*

DATE 4/13/17 4/13/17 4/27/17 OFFICE OGC* NRR/DPR/PRLB NAME JWachutka AAdams (LTran for)

DATE 5/23/17 5/24/17